U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935304) titled 'A Study Assessing Eloralintide (LY3841136) in Healthy Participants' on Nov. 09.
Brief Summary: The main purpose of this study is to investigate the effects of where Eloralintide is subcutaneously (SC) injected into the body and to investigate how the body processes an intravenous (IV) dose of Eloralintide. Blood tests will be performed to investigate how the study drug affects the body. For each participant, the study will last about 12 weeks and will include a stay in the Clinical Research Unit (CRU) lasting 6 nights.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Eloralintide
...